INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 222 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,000 | 0.0% | 180 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | -95.8% | 180 | -96.7% | 0.00% | -100.0% |
| Q4 2020 | $48,000 | -22.6% | 5,380 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $62,000 | -92.9% | 5,380 | -95.8% | 0.00% | -88.5% |
| Q4 2015 | $870,000 | +0.3% | 129,420 | -13.7% | 0.03% | -21.2% |
| Q3 2015 | $867,000 | -29.2% | 149,930 | -0.0% | 0.03% | -19.5% |
| Q2 2015 | $1,224,000 | +2.1% | 149,960 | +2.0% | 0.04% | +2.5% |
| Q1 2015 | $1,199,000 | +60.1% | 146,969 | +80.1% | 0.04% | +53.8% |
| Q4 2014 | $749,000 | -15.4% | 81,590 | -9.1% | 0.03% | -21.2% |
| Q3 2014 | $885,000 | -9.1% | 89,800 | -0.3% | 0.03% | -8.3% |
| Q2 2014 | $974,000 | – | 90,110 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |